None listed
Conditions
Interventions
Intervention1: GUDUCHI CAPSULE: GUDUCHI CAPSULE-250 mg X 2 capsules b.d, for one month
Control Intervention1: Standard Prophylactic Care: Standard Prophylactic Care recommended by Government of Telang
Sponsors
CCRASNIIMH
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult Male or Female subjects above the age of 18 years to 68 years of age 2. Subjects who are froma community where at least 1 confirmed case is already identified. 3. Subjects who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study
Exclusion criteria
Exclusion criteria: 1. Pregnant and Lactating females 2. Known cases of uncontrolled Diabetes and Hypertension. 3. Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening 4. Subjects having immune compromised status like HIV, Hepatitis, Tuberculosis, Cancer etc. 5. Subjects taking Steroid treatment and or any kind of immunosuppressive therapy 6. Subjects participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study. 7. Subjects having a past history of allergy to any medicine that is part of the Ayurvedic intervention. 8. Other conditions, which in the opinion of the investigators, makes the patient unsuitable for enrolment or could interfere with his participation in, and completion of the protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Comparative assessment of occurrence of COVID-19 infection in healthy volunteers in community having at least 1 confirmed case already identified with control arm of Standard Prophylactic CareTimepoint: 0 15 30 45 days | — |
Secondary
| Measure | Time frame |
|---|---|
| a) Assessment of subjects not requiring hospitalization b) Severity of symptoms of hospitalized patients in wards c) Patients requiring ICU admission / Ventilator support 3. Safety assessment by evaluation of occurrence of AE/SAE due to consumption of Ayurveda InterventionTimepoint: 0 15 30 45 days | — |
Countries
India
Contacts
Public ContactDr P V V Prasad
NIIMH-CCRAS, Ministry of AYUSH
Outcome results
None listed